DLG
ABBV icon

Daniel L. Goodwin’s AbbVie ABBV Stock Holding History

Daniel L. Goodwin’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$252K Hold
1,690
– – 0.12% 77
2023
Q2 		$228K Hold
1,690
– – 0.11% 78
2023
Q1 		$269K Buy
+1,690
New +$258K 0.14% 66

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Daniel L. Goodwin's ABBV Position: Q3 2023 in Review

Daniel L. Goodwin held its AbbVie (ABBV) position steady in Q3 2023 at 1,690 shares worth $252K. The position accounts for 0.12% of the portfolio, ranked #77.

Daniel L. Goodwin first reported a position in ABBV in Q1 2023 and has held it in 3 quarters since. The position peaked at $269K in Q1 2023. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Daniel L. Goodwin held 1,690 shares of AbbVie worth $252K as of Q3 2023.
  • Daniel L. Goodwin left its AbbVie share count unchanged in Q3 2023.
  • AbbVie made up 0.12% of Daniel L. Goodwin's portfolio in Q3 2023, its #77 holding.
  • Daniel L. Goodwin first reported a position in AbbVie in Q1 2023 and has held it in 3 quarters since.
  • Daniel L. Goodwin's AbbVie position peaked at $269K in Q1 2023.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Daniel L. Goodwin's 13F filing for Q3 2023, filed 24 Oct 2023.